Monte Rosa Therapeutics Company
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.
Investors
Connections
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2018-01-01
Industry:
Drug Discovery & Development
Employee Number:
101-250
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 917-363-0113
Investors:
BlackRock, Cormorant Asset Management, Fidelity, New Enterprise Associates, RTW Investments
Ipo Status:
public
Stock Symbol:
GLUE
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Alexander Flohr